Literature DB >> 24572762

Dabigatran-induced lupus temporarily preventing blood group determination.

Claudia Stöllberger1, Gabriele Krutisch, Josef Finsterer, Hermann Maximilian Wolf.   

Abstract

Epistaxis resulted in severe anemia in an 89-year-old Caucasian woman under a therapy with dabigatran for 12 months because of atrial fibrillation. Correction of the anemia was difficult because it was impossible to assess her blood group due to polyagglutination. Since hospital records disclosed that in 2011, her blood group was O positive, acquired polyagglutination was assumed. After 66 days, it was again possible to assess the blood group as O positive. Immunologic investigations disclosed that antinuclear antibodies and antihistone antibodies were elevated, and antibodies to double-stranded DNA were negative. Drug-induced lupus was diagnosed due to the autoantibody profile detected.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24572762     DOI: 10.1097/MBC.0000000000000099

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  2 in total

Review 1.  Dabigatran must be used carefully: literature review and recommendations for management of adverse events.

Authors:  Shan Lin; Yan Wang; Lei Zhang; Wei Guan
Journal:  Drug Des Devel Ther       Date:  2019-05-06       Impact factor: 4.162

Review 2.  Rheumatic diseases induced by drugs and environmental factors: the state-of-the-art - part one.

Authors:  Karolina Niklas; Arkadiusz A Niklas; Dominik Majewski; Mariusz Puszczewicz
Journal:  Reumatologia       Date:  2016-07-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.